But non-fiber types may actually boost risk of disease, Fred Hutch analysis finds
Oct. 8, 2014
| By JoNel Aleccia / Fred Hutch News Service
When irregularity strikes, what do you do? If you’re like roughly 20 percent of Americans, you reach for a laxative to help ease symptoms of occasional constipation. But a large new prospective study of more than 75,000 adults in western Washington finds that the type of laxative you take may influence your risk for colorectal cancer.
Citing skin cancer risks, new FDA regulations caution against use by teens
May 29, 2014
| By Mary Engel
Indoor tanning beds, booths and sunlamps that emit ultraviolet radiation must now carry a visible black box warning that they should not be used by anyone under age 18 because they increase the risk of skin cancer, according to new regulations issued by the U.S. Food and Drug Administration.
Conversely, Brasky and colleagues find high percentage of unhealthy trans-fatty acids linked with decreased high-grade prostate cancer risk
May 2, 2011
| By Kristen Woodward
Analyzing data from a nationwide study involving more than 3,400 men, Fred Hutchinson Cancer Research Center Public Health Sciences Division researchers found that males with the highest blood percentages of docosahexaenoic acid, an inflammation-lowering omega-3 fatty acid commonly found in fatty fish, have two-and-a-half-times the risk of developing aggressive, high-grade prostate cancer compared to men with the lowest DHA levels.
PHS study first to demonstrate potential link with supplements
July 12, 2010
Researchers in the Public Health Sciences Division of the Fred Hutchinson Cancer Research Center found regular use of fish oil supplements, which contain high levels of the omega-3 fatty acids EPA and DHA, is associated with a 32 percent reduction in breast cancer risk. The findings—the first to demonstrate such a link—were published in the July issue of the journal Cancer Epidemiology, Biomarkers & Prevention.